I've discussed Actemra often in this blog, and once again it has been in the news: the British medical journal The Lancet earlier this month published two studies that showed its effectiveness in the treatment of rheumatoid arthritis and juvenile rheumatoid arthritis. Actemra, for those of you who may not yet know, is a drug that is currently being considered by the FDA for use in Rheumatoid Arthritis.
The results from the so-called OPTION trial were from a major Phase III international...

